Machine Learning For Drug Discovery! #YCombinator #MachineLearning #COVID

COVID 19 has sparked fear in the world as of 2020. Luckily there are companies like Postera that are using technology to ensure that future pandemics are handled much more efficiently! Who knew that Machine Learning could help us find cures to diseases that haven't even emerged as yet!

On the second Y Combinator Series episode of the Customer Discovercast, we spoke to Aaron Morris , Cofounder of Postera about his journey from Data Scientist to Y combinator backed startup founder.

Tune in to learn about Aaron's experience at Y combinator (They reached out to HIM!!), crowdsourcing a solution for future COVID mutations!

You can listen to the Customer Discovercast by using the following links for Apple https://apple.co/2JCLsHD​ and Spotify https://open.spotify.com/show/6lc0msA...​ but we’re also on every major podcast directory!

Aaron is a mathematician by training, completing his studies in Applied Mathematics at Oxford University where he also met Alpha, one of PostEra’s co-founders. He then spent 5 years in Finance as a Data Scientist and Trader before founding PostEra along with Alpha and Matt in October 2019.

PostEra uses machine learning to help discover novel drugs. We offer medicinal chemistry as a service, with a focus on how to make compounds. We have partnered with drug hunters in large pharma like Pfizer and with new biotechs like NeuroLucent, to expedite their own drug discovery campaigns while also offering a cloud-based platform called Manifold as a one-stop-shop for making compounds. Through the platform we hope to democratise access to machine learning technology to help every drug hunter advance their own drug discovery efforts.

Linkedin
Postera